Last reviewed · How we verify

NCT01503775: TRULINE

TRUfill®'s Line in Intracranial aNeurysm Embolisation

Completed Last updated 20 June 2017
What this trial tests

trial in Aneurysms in 171 participants. Completed in 1 August 2014.

Timeline
1 December 2011
Primary endpoint
1 August 2014
1 August 2014

Quick facts

Lead sponsorCodman & Shurtleff
StatusCompleted
Study typeOBSERVATIONAL
Enrollment171
Start date1 December 2011
Primary completion1 August 2014
Estimated completion1 August 2014
Sites7 locations across France

Conditions studied

Sponsor

Codman & Shurtleff — full company profile →

Who can join

18 and older, any sex, with Aneurysms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the long term efficacy and safety of the CODMAN TRUFILL®'s line of coils in the treatment of patients with intracranial ruptured or non-ruptured aneurysms in real-life routine clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aneurysms

Currently open trials in the same condition.

Other Codman & Shurtleff trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01503775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing